KERYX BIOPHARMACEUTICALS INC Business Finance Contracts & Agreements
21 Contracts & Agreements
- Assignment Agreements (1 contract)
- Exchange Agreements (3)
- Indenture Agreements (4)
- Loan Agreements (1)
- Note Agreements (1)
- Purchase Agreements (1)
- Registration Rights Agreements (2)
- Release Agreements (3)
- Stock Agreements (1)
- Underwriting Agreements (3)
- Warrant Agreements (1)
- First Supplemental Indenture dated November 8, 2018, by and between Keryx Biopharmaceuticals, Inc. and The Bank of New York Mellon Trust Company, N.A. to the Indenture dated as of... (Filed With SEC on November 8, 2018)
- Loan and Security Agreement dated July 18, 2018, between Keryx Biopharmaceuticals, Inc. and Silicon Valley Bank (Filed With SEC on July 20, 2018)
- Notes Conversion Agreement, dated as of June 28, 2018, by and among Keryx Biopharmaceuticals, Inc., Baupost Group Securities, L.L.C. and, with respect to certain sections only,... (Filed With SEC on June 28, 2018)
- Registration Rights Agreement dated as of May 9, 2018, between Keryx Biopharmaceuticals, Inc. and Baupost Group Securities, L.L.C (Filed With SEC on May 10, 2018)
- Indenture dated as of May 9, 2018, between Keryx Biopharmaceuticals, Inc. and The Bank of New York Mellon Trust Company, N.A (Filed With SEC on May 10, 2018)
- Notes Exchange Agreement dated as of May 8, 2018, between Keryx Biopharmaceuticals, Inc. and Baupost Group Securities, L.L.C (Filed With SEC on May 10, 2018)
- FIRSTSUPPLEMENTAL INDENTURE (Filed With SEC on April 10, 2017)
- Confidential Materials Omitted, Designated Herein as [***], and Filed Separately with the Securities and Exchange Commission Master Manufacturing Services Agreement September 27,... (Filed With SEC on March 1, 2017)
- REGISTRATIONRIGHTS AGREEMENT BY AND AMONG KERYX BIOPHARMACEUTICALS, INC. AND BAUPOST GROUPSECURITIES, L.L.C. DATED AS OF OCTOBER 15, 2015 TABLE OF CONTENTS (Filed With SEC on October 19, 2015)
- KERYX BIOPHARMACEUTICALS, INC. ZERO COUPON CONVERTIBLE SENIOR NOTES DUE 2020 INDENTURE DATED AS OF OCTOBER 15, 2015 THE BANK OF NEWYORK MELLON TRUST COMPANY, N.A., AS TRUSTEE... (Filed With SEC on October 19, 2015)
- KeryxBiopharmaceuticals, Inc. 9,166,667 Shares Common Stock ($0.001par value) Underwriting Agreement (Filed With SEC on January 27, 2015)
- KeryxBiopharmaceuticals, Inc. 6,900,000 Shares Common Stock ($0.001par value) Underwriting Agreement (Filed With SEC on January 28, 2014)
- Keryx Biopharmaceuticals, Inc. 8,234,000 Shares Common Stock ($0.001 par value) Underwriting Agreement (Filed With SEC on February 5, 2013)
- COMMONSTOCK GREENSHOE WARRANT KeryxBiopharmaceuticals, Inc. (Filed With SEC on October 1, 2009)
- SETTLEMENTAGREEMENT AND GENERAL RELEASE (Filed With SEC on August 12, 2009)
- KERYX BIOPHARMACEUTICALS, INC. 2007 CHIEF ACCOUNTING OFFICER INDUCEMENT STOCK OPTION PLAN SPECIAL NONSTATUTORY STOCK OPTION AGREEMENT (Filed With SEC on May 7, 2007)
- ASSIGNMENT AND ASSUMPTION AGREEMENT (Filed With SEC on November 8, 2006)
- SECURITIES PURCHASE AGREEMENT (Filed With SEC on March 30, 2006)
- Cooperative Research and Development Agreement (CACR - 0774) Clinical Development of Perifosine Sherry Ansher, Ph.D. Janet Dancey, M.D. CTEP DCTD Dr. rer. nat. RainerVoegeli ASTA... (Filed With SEC on March 30, 2004)
- COMPREHENSIVE RELEASE AGREEMENT (Filed With SEC on March 30, 2004)
- RELEASE AGREEMENT (Filed With SEC on March 30, 2004)
